3.57
price up icon7.21%   0.24
after-market アフターアワーズ: 3.54 -0.03 -0.84%
loading
前日終値:
$3.33
開ける:
$3.38
24時間の取引高:
2.76M
Relative Volume:
0.78
時価総額:
$588.74M
収益:
$101.21M
当期純損益:
$-569.00K
株価収益率:
-178.50
EPS:
-0.02
ネットキャッシュフロー:
$-56.88M
1週間 パフォーマンス:
+9.51%
1か月 パフォーマンス:
+11.91%
6か月 パフォーマンス:
+379.65%
1年 パフォーマンス:
+258.54%
1日の値動き範囲:
Value
$3.36
$3.59
1週間の範囲:
Value
$3.22
$3.59
52週間の値動き範囲:
Value
$0.40
$3.9099

Cytomx Therapeutics Inc Stock (CTMX) Company Profile

Name
名前
Cytomx Therapeutics Inc
Name
セクター
Healthcare (1135)
Name
電話
650.515.3185
Name
住所
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
職員
121
Name
Twitter
@cytomxinc
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
CTMX's Discussions on Twitter

CTMX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CTMX
Cytomx Therapeutics Inc
3.57 549.16M 101.21M -569.00K -56.88M -0.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-22 開始されました Cantor Fitzgerald Overweight
2025-09-17 再開されました Barclays Overweight
2025-07-31 開始されました Oppenheimer Outperform
2025-05-15 アップグレード H.C. Wainwright Neutral → Buy
2025-04-14 再開されました Piper Sandler Overweight
2024-05-28 アップグレード Piper Sandler Neutral → Overweight
2024-05-09 アップグレード Wedbush Neutral → Outperform
2024-05-06 アップグレード Jefferies Hold → Buy
2024-04-22 アップグレード JP Morgan Underweight → Neutral
2022-11-14 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-07-07 ダウングレード Jefferies Buy → Hold
2022-07-07 ダウングレード Mizuho Buy → Neutral
2022-07-07 ダウングレード Piper Sandler Overweight → Neutral
2022-07-07 ダウングレード Wedbush Outperform → Neutral
2022-06-24 開始されました BMO Capital Markets Outperform
2022-01-18 アップグレード Barclays Underweight → Overweight
2021-11-15 開始されました BTIG Research Buy
2021-05-28 ダウングレード Barclays Equal Weight → Underweight
2021-03-29 開始されました JP Morgan Overweight
2021-03-23 アップグレード Jefferies Hold → Buy
2020-09-22 ダウングレード Guggenheim Buy → Neutral
2020-06-01 ダウングレード Jefferies Buy → Hold
2020-05-14 繰り返されました H.C. Wainwright Buy
2020-03-24 アップグレード Wedbush Neutral → Outperform
2020-03-04 開始されました Barclays Equal Weight
2019-11-20 開始されました Guggenheim Buy
2019-11-11 ダウングレード Wedbush Outperform → Neutral
2019-06-13 開始されました Mizuho Buy
2019-05-14 開始されました Cantor Fitzgerald Overweight
2019-03-11 開始されました Barclays Overweight
2018-11-26 開始されました Piper Jaffray Overweight
2018-10-15 開始されました Goldman Neutral
2018-09-13 開始されました H.C. Wainwright Buy
2018-06-01 開始されました SunTrust Buy
2018-01-05 開始されました Citigroup Buy
2017-09-08 開始されました Wedbush Outperform
2017-03-27 開始されました H.C. Wainwright Buy
2017-03-02 開始されました Instinet Buy
2017-01-03 ダウングレード Oppenheimer Outperform → Perform
2015-11-02 開始されました Oppenheimer Outperform
すべてを表示

Cytomx Therapeutics Inc (CTMX) 最新ニュース

pulisher
01:14 AM

How CytomX Therapeutics Inc. stock performs in rate cut cyclesJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com

01:14 AM
pulisher
12:50 PM

Using data filters to optimize entry into CytomX Therapeutics Inc.Analyst Downgrade & Entry and Exit Point Strategies - newser.com

12:50 PM
pulisher
12:48 PM

What dividend safety rating applies to CytomX Therapeutics Inc. (6C1) stockBond Market & AI Forecasted Entry and Exit Points - newser.com

12:48 PM
pulisher
12:38 PM

Published on: 2025-11-02 12:38:04 - newser.com

12:38 PM
pulisher
11:37 AM

What insider purchases suggest about CytomX Therapeutics Inc. (6C1) stockMarket Sentiment Review & Daily Momentum Trading Reports - newser.com

11:37 AM
pulisher
04:31 AM

Why CytomX Therapeutics Inc. (6C1) stock is a strong buy callJuly 2025 Final Week & Real-Time Volume Spike Alerts - newser.com

04:31 AM
pulisher
03:14 AM

What earnings margins imply for CytomX Therapeutics Inc. (6C1) stockJuly 2025 Intraday Action & Daily Volume Surge Signals - newser.com

03:14 AM
pulisher
01:46 AM

Using Ichimoku Cloud for CytomX Therapeutics Inc. technicalsQuarterly Portfolio Report & Long-Term Capital Growth Strategies - newser.com

01:46 AM
pulisher
Nov 01, 2025

How to integrate CytomX Therapeutics Inc. into portfolio analysis tools2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is CytomX Therapeutics Inc. (6C1) stock a buy on weakness2025 Retail Activity & AI Driven Price Forecasts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

How CytomX Therapeutics Inc. stock reacts to oil pricesJuly 2025 Short Interest & Weekly Return Optimization Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Why analysts maintain buy rating on CytomX Therapeutics Inc. (6C1) stockShort Setup & Real-Time Volume Triggers - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What drives CytomX Therapeutics Inc 6C1 stock priceMarket Sentiment Report & Trusted Financial Advisors at No Cost - earlytimes.in

Oct 31, 2025
pulisher
Oct 31, 2025

Key metrics from CytomX Therapeutics Inc.’s quarterly dataJuly 2025 Opening Moves & Fast Gaining Stock Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is CytomX Therapeutics Inc. (6C1) stock considered safe havenTrade Analysis Summary & Free Technical Pattern Based Buy Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

CytomX Therapeutics (CTMX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Building trade automation scripts for CytomX Therapeutics Inc.2025 Macro Impact & AI Driven Stock Movement Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can CytomX Therapeutics Inc. stock reach $100 price targetJuly 2025 Update & AI Forecast Swing Trade Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How CytomX Therapeutics Inc. stock compares to market leadersJuly 2025 Summary & Real-Time Stock Price Movement Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What analyst consensus implies for CytomX Therapeutics Inc. (6C1) stock2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Oppenheimer Remains a Buy on CytomX Therapeutics (CTMX), Sets a $7 PT - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Will CytomX Therapeutics Inc. stock reach Wall Street targetsPortfolio Update Report & Breakout Confirmation Trade Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

CytomX Therapeutics, Inc. to Report Third Quarter Financial Results on November 6, 2025 - Quiver Quantitative

Oct 30, 2025
pulisher
Oct 30, 2025

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

CytomX Therapeutics (NASDAQ: CTMX) sets third-quarter results for Nov. 6, with webcast - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 05:08:21 - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Visual analytics tools that track CytomX Therapeutics Inc. performanceMarket Sentiment Report & Technical Pattern Alert System - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

CytomX (CTMX) reports 650,000 CBO stock options at $3.74 - Stock Titan

Oct 29, 2025
pulisher
Oct 29, 2025

CTMX insider filing: Form 3 shows zero beneficial ownership - Stock Titan

Oct 29, 2025
pulisher
Oct 29, 2025

How CytomX Therapeutics Inc. (6C1) stock behaves in tightening cyclesGlobal Markets & Community Trade Idea Sharing Platform - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-29 04:21:57 - newser.com

Oct 29, 2025

Cytomx Therapeutics Inc (CTMX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
大文字化:     |  ボリューム (24 時間):